These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 23044342)

  • 21. Relief of inflammatory pain in rats by local use of the selective P2X7 ATP receptor inhibitor, oxidized ATP.
    Dell'Antonio G; Quattrini A; Cin ED; Fulgenzi A; Ferrero ME
    Arthritis Rheum; 2002 Dec; 46(12):3378-85. PubMed ID: 12483745
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acute pain management in burn patients: appraisal and thematic analysis of four clinical guidelines.
    Gamst-Jensen H; Vedel PN; Lindberg-Larsen VO; Egerod I
    Burns; 2014 Dec; 40(8):1463-9. PubMed ID: 25277698
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Patient-controlled analgesia with fentanyl for burn dressing changes.
    Prakash S; Fatima T; Pawar M
    Anesth Analg; 2004 Aug; 99(2):552-5, table of contents. PubMed ID: 15271737
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Benefit of hydrocolloid SSD dressing in the outpatient management of partial thickness burns.
    Muangman P; Muangman S; Opasanon S; Keorochana K; Chuntrasakul C
    J Med Assoc Thai; 2009 Oct; 92(10):1300-5. PubMed ID: 19845237
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Play and heal: randomized controlled trial of Ditto™ intervention efficacy on improving re-epithelialization in pediatric burns.
    Brown NJ; Kimble RM; Rodger S; Ware RS; Cuttle L
    Burns; 2014 Mar; 40(2):204-13. PubMed ID: 24360745
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Influence of nuclear factor-kappaB activation on the expression of cytokines in monocytes stimulated by burn serum].
    Li ZQ; Huang YS; Yang ZC; Wang JH
    Zhonghua Shao Shang Za Zhi; 2005 Dec; 21(6):434-7. PubMed ID: 16480624
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of various inducers on the expression of P2X7 receptor in human peripheral blood mononuclear cells.
    Zhang XJ; Zheng GG; Ma XT; Lin YM; Song YH; Wu KF
    Sheng Li Xue Bao; 2005 Apr; 57(2):193-8. PubMed ID: 15830104
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Down-regulation of purinergic P2X7 receptor expression and intracellular calcium dysregulation in peripheral blood mononuclear cells of patients with amyotrophic lateral sclerosis.
    Liu J; Prell T; Stubendorff B; Keiner S; Ringer T; Gunkel A; Tadic V; Goldhammer N; Malci A; Witte OW; Grosskreutz J
    Neurosci Lett; 2016 Sep; 630():77-83. PubMed ID: 27453058
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression and function of the purinergic receptor P2X7 in patients with pulmonary tuberculosis.
    Franco-Martínez S; Niño-Moreno P; Bernal-Silva S; Baranda L; Rocha-Meza M; Portales-Cervantes L; Layseca-Espinosa E; González-Amaro R; Portales-Pérez D
    Clin Exp Immunol; 2006 Nov; 146(2):253-61. PubMed ID: 17034577
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Liposomal IGF-1 gene transfer modulates pro- and anti-inflammatory cytokine mRNA expression in the burn wound.
    Spies M; Nesic O; Barrow RE; Perez-Polo JR; Herndon DN
    Gene Ther; 2001 Sep; 8(18):1409-15. PubMed ID: 11571581
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Burn injury pain: the continuing challenge.
    Summer GJ; Puntillo KA; Miaskowski C; Green PG; Levine JD
    J Pain; 2007 Jul; 8(7):533-48. PubMed ID: 17434800
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effects of genistein and puerarin on the activation of nuclear factor-kappaB and the production of tumor necrosis factor-alpha in asthma patients.
    Liu XJ; Zhao J; Gu XY
    Pharmazie; 2010 Feb; 65(2):127-31. PubMed ID: 20225658
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analgesia and sedation for children undergoing burn wound care.
    Bayat A; Ramaiah R; Bhananker SM
    Expert Rev Neurother; 2010 Nov; 10(11):1747-59. PubMed ID: 20977331
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inflammasome activation in bovine monocytes by extracellular ATP does not require the purinergic receptor P2X7.
    Hussen J; Düvel A; Koy M; Schuberth HJ
    Dev Comp Immunol; 2012 Oct; 38(2):312-20. PubMed ID: 22728096
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A randomised crossover trial of patient controlled intranasal fentanyl and oral morphine for procedural wound care in adult patients with burns.
    Finn J; Wright J; Fong J; Mackenzie E; Wood F; Leslie G; Gelavis A
    Burns; 2004 May; 30(3):262-8. PubMed ID: 15082356
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of post-burn neuropathic pain: evaluation of pregablin.
    Wong L; Turner L
    Burns; 2010 Sep; 36(6):769-72. PubMed ID: 20362400
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Glucan phosphate treatment attenuates burn-induced inflammation and improves resistance to Pseudomonas aeruginosa burn wound infection.
    Lyuksutova OI; Murphey ED; Toliver-Kinsky TE; Lin CY; Cui W; Williams DL; Sherwood ER
    Shock; 2005 Mar; 23(3):224-32. PubMed ID: 15718919
    [TBL] [Abstract][Full Text] [Related]  

  • 38. P2X receptors and modulation of pain transmission: focus on effects of drugs and compounds used in traditional Chinese medicine.
    Liang S; Xu C; Li G; Gao Y
    Neurochem Int; 2010 Dec; 57(7):705-12. PubMed ID: 20863868
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Potential Involvement of P2 Receptors in the Pathological Processes of Hyperthyroidism: A Pilot Study.
    Hong W; Li G; Nie Y; Zou L; Zhang X; Liu S; Li G; Xu H; Zhang CP; Liang S
    Ann Clin Lab Sci; 2016 May; 46(3):254-9. PubMed ID: 27312548
    [TBL] [Abstract][Full Text] [Related]  

  • 40. P2X4 receptor regulates P2X7 receptor-dependent IL-1β and IL-18 release in mouse bone marrow-derived dendritic cells.
    Sakaki H; Fujiwaki T; Tsukimoto M; Kawano A; Harada H; Kojima S
    Biochem Biophys Res Commun; 2013 Mar; 432(3):406-11. PubMed ID: 23428419
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.